Major pharmaceutical company GlaxoSmithKline, alongside smaller company XenoPort inc. released a statement this week saying that their diabetes drug Solzira failed to pass a Phase 2 study to treat diabetic neuropathy damage to the extremities of the body.
However, the response may be down to statistical glitch caused by an unexpectedly high placebo-response rate. According to XenoPort, placebo response of this nature is not uncommon when it comes to diabetic peripheral neuropathy, and can easily cause the failure of a trial.
The drug is yet to be reviewed or approved by the Food and Drug Administration, to which it has been submitted as a treatment for restless leg syndrome. Diabetic neuropathy is an extremely common diabetes complication, caused when fluctuations in blood sugar levels damage nerve endings throughout the peripheral extremities of the body.
Diabetes drug fails in study
Mon, 27 Apr 2009
Recommended links
Diabetes newsletterDiabetes based financial services
Diabetes forum
Diabetes myLifestyle
Diabetes UK to lead care training
Good fat can prevent diabetes
Journal retracts diabetes study
Novo claim study confirms diabetes drug weight gain inhibition
Glaxo plays down diabetes drug study
New study reveals diabetes secrets
New study on diabetes in children
Side effects for diabetes drug in head-to-head study
New diabetes and depression study
Harvard fish study led to diabetes breakthroughs
Insulin pumps for diabetes could endanger teenagers, study says
Government halts diabetes study
Diabetes sugar study from carrot cake
Hot flash study examines diabetes
New study contradicts trial
Study involving flavonoids, diabetes and alcohol
Asian diabetes focus of study
Diabetes and depression study
Finance shortfall could halt unique diabetes and obesity study
New study turns indigenous diabetes theory on head
Diabetes television study
Diabetes study predicts amputation infection risk
Heart disease and diabetes connection revealed by study
Diabetes drug fails study
Study finds diabetes eats an hour a day for children
6000 volunteers for diabetes study
Healthcare study confirms role of intensive care
New diabetes study in London
Huge Canadian type 2 diabetes study
Study to assess drugs in adolescents with diabetes
New study important for diabetes
Promising diabetes study in mice
Chinese study reveals diabetes conclusions
Hopeful diabetes study a let down
New Gestational diabetes study
Criticism for cup-size diabetes study
Diabetes study shows amputation risk
Diabetes study leak confirmed
